Literature DB >> 23521001

A comprehensive ligand based mapping of the σ₂ receptor binding pocket.

Derek J Rhoades, David H Kinder, Tarek M Mahfouz1.   

Abstract

The sigma (σ) receptor system consists of at least two major receptor subtypes: σ₁ and σ₂. Several potential therapeutic applications would benefit from structural knowledge of the σ₂ receptor but gaining this knowledge has been hampered by the difficulties associated with its isolation and, thus, characterization. Here, a ligand based approach has been adopted using the program PHASE® and a group of 41 potent and structurally diverse σ₂ ligands to develop several pharmacophore models for different families of σ₂ ligands. These pharmacophores were analyzed to identify the different binding modes to the receptor and were combined together to construct a comprehensive pharmacophore that was used to develop a structural model for the σ₂ binding pocket. A total of six binding modes were identified and could be classified as neutral or charged modes. The results presented here also indicate the significance of hydrophobic interactions to σ₂ binding and the requirement of hydrogen bonding interactions to increase the affinity for this receptor subtype. This work adds breadth to our knowledge of this receptor's binding site, and should contribute significantly to the development of novel selective σ₂ ligands.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 23521001     DOI: 10.2174/1573406409999131119103621

Source DB:  PubMed          Journal:  Med Chem        ISSN: 1573-4064            Impact factor:   2.745


  7 in total

1.  Norbenzomorphan Framework as a Novel Scaffold for Generating Sigma 2 Receptor/PGRMC1 Subtype-Selective Ligands.

Authors:  James J Sahn; Timothy R Hodges; Jessica Z Chan; Stephen F Martin
Journal:  ChemMedChem       Date:  2016-02-24       Impact factor: 3.466

2.  Sigma receptors [σRs]: biology in normal and diseased states.

Authors:  Colin G Rousseaux; Stephanie F Greene
Journal:  J Recept Signal Transduct Res       Date:  2015-06-09       Impact factor: 2.092

3.  Synthesis, Cytotoxicity Evaluation, and Computational Insights of Novel 1,4-Diazepane-Based Sigma Ligands.

Authors:  Daniele Zampieri; Sara Fortuna; Antonella Calabretti; Maurizio Romano; Renzo Menegazzi; Dirk Schepmann; Bernhard Wünsch; Maria Grazia Mamolo
Journal:  ACS Med Chem Lett       Date:  2019-12-16       Impact factor: 4.345

4.  Ether modifications to 1-[2-(3,4-dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazine (SA4503): effects on binding affinity and selectivity for sigma receptors and monoamine transporters.

Authors:  Rong Xu; Sarah A Lord; Ryan M Peterson; Emily A Fergason-Cantrell; John R Lever; Susan Z Lever
Journal:  Bioorg Med Chem       Date:  2014-11-11       Impact factor: 3.641

5.  Pharmacological Analysis of the Anti-epileptic Mechanisms of Fenfluramine in scn1a Mutant Zebrafish.

Authors:  Jo Sourbron; Ilse Smolders; Peter de Witte; Lieven Lagae
Journal:  Front Pharmacol       Date:  2017-04-06       Impact factor: 5.810

6.  Computational investigation of potent inhibitors against SARS-CoV-2 2'-O-methyltransferase (nsp16): Structure-based pharmacophore modeling, molecular docking, molecular dynamics simulations and binding free energy calculations.

Authors:  Liying Shi; Zeyu Wen; Yu Song; Jian Wang; Dayong Yu
Journal:  J Mol Graph Model       Date:  2022-08-18       Impact factor: 2.942

Review 7.  Sigma Receptors as Endoplasmic Reticulum Stress "Gatekeepers" and their Modulators as Emerging New Weapons in the Fight Against Cancer.

Authors:  Anna Tesei; Michela Cortesi; Alice Zamagni; Chiara Arienti; Sara Pignatta; Michele Zanoni; Mayra Paolillo; Daniela Curti; Marta Rui; Daniela Rossi; Simona Collina
Journal:  Front Pharmacol       Date:  2018-07-10       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.